Log in or Sign up for Free to view tailored content for your specialty!
Practice Management News
Q&A: Reexamining racial factors in clinical algorithms
A reexamination of factoring race into clinical equations for patient care will require changes at each step of the algorithm life cycle, according to an expert.
Novel equations estimate long-term risk from cardiovascular-kidney-metabolic syndrome
PHILADELPHIA — A speaker unveiled the American Heart Association’s new PREVENT equations to evaluate 10- and 30-year absolute risk associated with cardiovascular-kidney-metabolic syndrome.
Log in or Sign up for Free to view tailored content for your specialty!
VIDEO: Unmet needs of patients with hyperphosphatemia
Healio spoke with Daniel Coyne, MD, professor of medicine in the nephrology division at Washington University School of Medicine, about the challenges of managing hyperphosphatemia, new treatments and therapies, unmet needs in hyperphosphatemia management and more.
VIDEO: Drugs in the pipeline for hyperphosphatemia management
Healio spoke with Daniel Coyne, MD, professor of medicine in the nephrology division at Washington University School of Medicine, about the challenges of managing hyperphosphatemia, new treatments and therapies, unmet needs in hyperphosphatemia management and more.
VIDEO: Biggest treatment challenges for patients with hyperphosphatemia
Healio spoke with Daniel Coyne, MD, professor of medicine in the nephrology division at Washington University School of Medicine, about the challenges of managing hyperphosphatemia, new treatments and therapies, unmet needs in hyperphosphatemia management and more.
VIDEO: Latest treatment advancements in hyperphosphatemia
Healio spoke with Daniel Coyne, MD, professor of medicine in the nephrology division at Washington University School of Medicine, about the challenges of managing hyperphosphatemia, new treatments and therapies, unmet needs in hyperphosphatemia management and more.
Obinutuzumab improves odds of complete renal response, cuts flare risk in lupus nephritis
SAN DIEGO — Obinutuzumab use increases the chances of achieving complete renal response and lowers the risk for kidney-related events and time to flare in lupus nephritis, according to data presented at ACR Convergence 2023.
How behavioral finance impacts physicians’ decision making
Investing in the financial markets is a complex endeavor influenced not only by economic factors and market dynamics but also by human behavior.
Heterogeneity in germline susceptibility to renal cell carcinoma has genetic screening implications
NASHVILLE, Tenn. — An analysis of germline susceptibility to renal cell carcinoma revealed considerable heterogeneity, according to findings presented at International Kidney Cancer Symposium: North America.
Executive order directs HHS to monitor AI safety in health care
President Joe Biden recently announced an executive order to establish standards for artificial intelligence safety, equity and security in health care and several other industries.
-
Headline News
FDA warns of potential liver injury with Veozah for menopausal hot flashes
September 12, 20242 min read -
Headline News
Video games improved mental health during COVID-19 pandemic
September 12, 20242 min read -
Headline NewsSeptember 12, 20240 min read
-
Headline News
FDA warns of potential liver injury with Veozah for menopausal hot flashes
September 12, 20242 min read -
Headline News
Video games improved mental health during COVID-19 pandemic
September 12, 20242 min read -
Headline NewsSeptember 12, 20240 min read